German Sleep Expert Urges Committee Not To Reverse-Switch Antihistamines
Executive Summary
Chair of the German Sleep Society, Ingo Fietze, calls on members of Germany's Expert Committee for Prescription to vote down the proposal to reverse-switch first-generation antihistamines with sedative effect for patients over the age of 65.
You may also be interested in...
Stada Says Lemocin’s OTC Status 'Vindicated' By German Switch Committee Decision
Stada's Lemocin cough lozenges survive a German reverse-switch threat, as does first generation anti-histamine dimenhydrinate, pointing to possible good news for the company's other major German OTC brand, Hoggar Night (doxylamine), which is also having its OTC status re-examined by the country's Expert Committee on Prescription.
Stada Blasts German Sleep Aid Reverse Switch
Stada criticizes German switch committee's recommendation to restrict access to first generation antihistamines with a sedative effect for over-65s.
German Switch Committee Meets: Sumatriptan Goes Again, Antihistamine Reverse-Switch Rejected, For Now
Germany’s Expert Committee for Prescription recommends prescription-to-OTC reclassifications of sumatriptan for migraines and liquid ibuprofen, but rejects an OTC switch for ketoprofen and the reverse-switch of sedative antihistamines for over 65s.